Bessemer Group Inc. cut its stake in Oracle Corporation (NYSE:ORCL – Free Report) by 57.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 754,610 shares of the enterprise software provider’s stock after selling 1,015,023 shares during the quarter. Bessemer Group Inc.’s holdings in Oracle were worth $212,227,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in the stock. Darwin Wealth Management LLC grew its stake in Oracle by 130.0% during the third quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after acquiring an additional 65 shares in the last quarter. Winnow Wealth LLC bought a new position in Oracle in the 2nd quarter valued at $28,000. Financial Consulate Inc. bought a new position in Oracle in the 3rd quarter valued at $37,000. Corundum Trust Company INC bought a new position in shares of Oracle in the third quarter worth $39,000. Finally, Kilter Group LLC purchased a new stake in shares of Oracle in the second quarter worth $30,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently commented on ORCL. Bank of America reduced their target price on Oracle from $368.00 to $300.00 and set a “buy” rating for the company in a research report on Thursday, December 11th. Mizuho set a $400.00 price target on Oracle in a research report on Monday, December 15th. Cantor Fitzgerald decreased their price objective on shares of Oracle from $400.00 to $320.00 and set an “overweight” rating on the stock in a research report on Thursday, December 11th. JMP Securities reissued a “market outperform” rating and issued a $342.00 price target on shares of Oracle in a report on Friday, October 17th. Finally, Piper Sandler dropped their price objective on shares of Oracle from $290.00 to $240.00 and set an “overweight” rating for the company in a report on Monday. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $296.03.
Oracle Trading Down 5.1%
NYSE ORCL opened at $146.75 on Thursday. The firm has a market cap of $421.63 billion, a PE ratio of 27.58, a price-to-earnings-growth ratio of 1.35 and a beta of 1.64. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72. The stock has a 50-day moving average of $191.31 and a 200-day moving average of $235.52. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28.
Oracle (NYSE:ORCL – Get Free Report) last issued its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.62. The firm had revenue of $16.06 billion for the quarter, compared to analysts’ expectations of $16.19 billion. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The business’s revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business earned $1.47 earnings per share. As a group, sell-side analysts forecast that Oracle Corporation will post 5 EPS for the current year.
Oracle Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 23rd. Shareholders of record on Friday, January 9th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Friday, January 9th. Oracle’s payout ratio is presently 37.59%.
More Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle Health won a multi-organization pilot in Canada for its Clinical AI Agent, validating commercial traction for Oracle’s healthcare AI products. Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
- Positive Sentiment: Oracle’s recent $25B bond offering reportedly attracted heavy demand, indicating strong investor appetite for its debt and suggesting financing channels are open. Oracle Stock (ORCL) Gains as $25B Bond Offering Attracts Heavy Demand
- Positive Sentiment: Some sell-side firms (e.g., Barclays) have reiterated bullish ratings and high price targets, implying analysts still see upside if Oracle executes its AI/data-center strategy. Barclays Reiterates Overweight on Oracle
- Neutral Sentiment: Oracle announced an equity distribution agreement and senior notes issuance to fund its plans — this provides capital but increases near-term financing activity and complexity. Oracle Bolsters Financing with Major Senior Notes Issuance
- Neutral Sentiment: Oracle continues product and go-to-market pushes (AI banking platform, enterprise AI agents) that could drive long-term growth but require heavy near-term capex. Oracle Reimagines Banking for the AI Era
- Neutral Sentiment: Strategic commentary ties Oracle’s massive data-center and power plans to a structural shift (e.g., MarketBeat piece on companies funding power and SMRs); long-term strategic rationale exists but is execution- and timeline-dependent. The Atomic Pivot: AI’s $50 Billion Power Move
- Negative Sentiment: Markets punished Oracle after management outlined plans to raise roughly $45–50B for AI infrastructure (debt and equity), stoking dilution and leverage fears and sparking the recent sell-off. Oracle (ORCL) Is Down 11.6% After Unveiling a US$45–50 Billion AI Infrastructure Capital Plan
- Negative Sentiment: Multiple law firms have filed or are soliciting clients for securities class actions tied to Oracle’s disclosures (senior notes/offering documents and the June–Dec 2025 class period), adding legal risk and headline pressure. Kessler Topaz Files Securities Fraud Class Action Against Oracle
- Negative Sentiment: Reports say banks are exploring selling billions in loans tied to Oracle’s data centers and the company may cut up to 30,000 jobs — both raise execution and integration risks and amplify downside sentiment. Oracle Stock (ORCL) Slips as Banks Explore Selling Its Data Center Loans Oracle May Slash Up to 30,000 Jobs
- Negative Sentiment: Analysts have trimmed price targets (BMO, Scotiabank among them) and commentary highlights investor anxiety about the size/timing of the capital raise and AI execution — contributing to the stock’s decline. Oracle Price Target Lowered at BMO
Insider Transactions at Oracle
In other Oracle news, Director Naomi O. Seligman sold 2,223 shares of the stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $196.61, for a total value of $437,064.03. Following the completion of the transaction, the director owned 25,596 shares in the company, valued at approximately $5,032,429.56. This represents a 7.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Douglas A. Kehring sold 35,000 shares of the company’s stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $194.89, for a total transaction of $6,821,150.00. Following the completion of the sale, the executive vice president owned 33,638 shares in the company, valued at approximately $6,555,709.82. This trade represents a 50.99% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 62,223 shares of company stock worth $12,136,764 over the last 90 days. 40.90% of the stock is currently owned by insiders.
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Further Reading
- Five stocks we like better than Oracle
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
